Neurol. praxi. 2022;23(1):14-17 | DOI: 10.36290/neu.2021.074

Congenital non-5q spinal muscular atrophy in children

MUDr. Eva Trúsiková, MUDr. Katarína Okáµová, PhD., prof. MUDr. Karol Králinský, PhD.
II. detská klinika SZU, Detská fakultná nemocnica s poliklinikou Banská Bystrica

Spinal muscular atrophies (SMAs) are genetic disorders that are clinically characterized by progressive muscle weakness and atrophy due to degeneration of the anterior horn cells. Initially, the disease was considered a purely autosomal recessive condition caused by mutations in the SMN1 gene on chromosome 5q13. However, recent developments in next-generation sequencing technologies have revealed a growing number of clinical conditions referred to as non-5q forms of spinal muscular atrophy. Although non-5q forms of SMA are very rare, they are clinically and genetically very heterogeneous diseases.

Keywords: spinal muscular atrophy, non-5q spinal muscular atrophy.

Received: September 13, 2021; Revised: September 30, 2021; Accepted: October 4, 2021; Prepublished online: October 4, 2021; Published: March 14, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Trúsiková E, Okáµová K, Králinský K. Congenital non-5q spinal muscular atrophy in children. Neurol. praxi. 2022;23(1):14-17. doi: 10.36290/neu.2021.074.
Download citation

References

  1. Auer-Grumbach M, Olschewski A, Papić L, et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet. 2010;42(2):160-164. Go to original source... Go to PubMed...
  2. Biasini F, Portaro S, Mazzeo A, et al. TRPV4 related scapulo­peroneal spinal muscular atrophy: report of an Italian family and review of the literature. Neuromuscul Disord. 2016;26(4-5): 312-315. Go to original source... Go to PubMed...
  3. Bosch AM, Abeling NG, Ijlst L, et al. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis. 2011;34(1):159-164. Go to original source... Go to PubMed...
  4. D'amico A, Mercuri E, Tiziano FD, et al. Spinal muscular atro­phy. Orphanet J Rare Dis. 2011;6:71. Go to original source... Go to PubMed...
  5. Darras BT. Non-5q spinal muscular atrophies: the alphanumeric soup thickens. Neurology. 2011;77(4):312-314. Go to original source... Go to PubMed...
  6. Fiorillo C, Moro F, Yi J, et al. Novel Dynein DYNC1H1 neck and motor domain mutations link distal spinal muscular atrophy and abnormal cortical development. Hum Mutat. 2014;35(3):298-302. Go to original source... Go to PubMed...
  7. Harms MB, Allred P, Gardner R Jr, et al. Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32. Neurology. 2010;75(6):539-546. Go to original source... Go to PubMed...
  8. Harms MB, Ori-McKenney KM, Scoto M, et al. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology. 2012;78(22):1714-1720. Go to original source... Go to PubMed...
  9. Herva R, Conradi NG, Kalimo H, et al. A syndrome of multiple congenital contractures: neuropathological analysis on five fetal cases. Am J Med Genet. 1988;29(1):67-76. Go to original source... Go to PubMed...
  10. Isozumi K, DeLong R, Kaplan J, et al. Linkage of scapuloperoneal spinal muscular atrophy to chromosome 12q24.1-q24.31. Hum Mol Genet. 1996;5(9):1377-1382. Go to original source... Go to PubMed...
  11. Knierim E, Hirata H, Wolf NI, et al. Mutations in subunits of the activating signal cointegrator 1 complex are associated with prenatal spinal muscular atrophy and congenital bone fractures. Am J Hum Genet. 2016;98(3):473-489. Go to original source... Go to PubMed...
  12. Narkis G, Ofir R, Manor E, et al. Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway. Am J Hum Genet. 2007;81(3):589-595. Go to original source... Go to PubMed...
  13. Oates EC, Rossor AM, Hafezparast M, et al. Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet. 2013;92(6):965-973. Go to original source... Go to PubMed...
  14. Peeters K, Litvinenko I, Asselbergh B, et al. Molecular defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance. Am J Hum Genet. 2013;92(6):955-964. Go to original source... Go to PubMed...
  15. Peeters K, Chamova T, Jordanovova A. Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies. Brain. 2014;137(11):2879-2896. Go to original source... Go to PubMed...
  16. Porro F, Rinchetti P, Magri F, et al. The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review. J Neurol Sci. 2014;346(1-2):35-42. Go to original source... Go to PubMed...
  17. Ramser J, Ahearn ME, Lenski C, et al. Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. Am J Hum Genet. 2008;82(1):188-193. Go to original source... Go to PubMed...
  18. Said E, Chong JX, Hempel M, et al. Survival beyond the perinatal period expands the phenotypes caused by mutations in GLE1. Am J Med Genet A. 2017;173(11):3098-3103. Go to original source... Go to PubMed...
  19. Smith C, Parboosingh JS, Boycott KM, et al. Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrum. Clin Genet. 2017;91(3):426-430. Go to original source... Go to PubMed...
  20. Teoh HL, Carey K, Sampaio H, et al. Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy. Neural Plasticity. 2017;2017:1-22. Go to original source... Go to PubMed...
  21. Voupala K, Ignatius J, Herva R. Lethal arthrogryposis with anterior horn cell disease. Human Pathology. 1995;26(1):12-19. Go to original source... Go to PubMed...
  22. Wan J, Yourshaw M, Mamsa H, et al. Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet. 2012;44(6):704-708. Go to original source... Go to PubMed...
  23. Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15(3):228-237. Go to original source... Go to PubMed...
  24. Yu F, Amintas S, Levade T, et al Acid ceramidase deficiency: Farber disease and SMA-PME. Orphanet J Rare Dis. 2018;13:121. Go to original source... Go to PubMed...
  25. Zhou J, Tawk M, Tiziano FD, et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am J Hum Genet. 2012;91(1):5-14. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.